Back
Crism Therapeutics 10K Form
Sell
40
AMMCF
Crism Therapeutics
Last Price:
6.7680
Seasonality Move:
-24.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMMCF News And Ratings
See the #1 stock for the next 7 days that we like better than AMMCF
AMMCF Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.08 |
| Price / Book: | 84.47 |
Profitability
| EPS (TTM): | -1.06360 |
|---|---|
| Net Income (TTM): | $-9.25M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Crism Therapeutics Earnings Forecast
Key Crism Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 10 years.
Crism Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | AMMCF |
| Website: | amurminerals.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AMMCF Technical Analysis vs Fundamental Analysis
Sell
40
Crism Therapeutics (AMMCF)
is a Sell
Is Crism Therapeutics a Buy or a Sell?
-
Crism Therapeutics stock is rated a Sell
The current Crism Therapeutics [AMMCF] share price is $6.7680. The Score for AMMCF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.